Skip to main content

Awards Funding Policy

Fiscal Year 2024 Interim Awards Funding Policy – ORIP

As referenced in NIH Guide Notice (NOT-OD-24-007), the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH), operates under the Continuing Appropriations Act, 2024 and Other Extensions Act (Public Law 118-015) signed by President Biden on September 30, 2023. This Act (CR) continues government operations through November 17, 2023, at the fiscal year (FY) 2023 enacted level, with no reduction. On November 16, 2023, the CR was extended through February 2, 2024 (NOT-OD-24-039). On January 19, 2024, the CR was extended through March 8, 2024 (NOT-OD-24-059). 

Consistent with NIH practices during the CRs of FYs 2006–2023, NIH Institutes and/or Centers may, at their discretion, issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award. Upward adjustments to awarded levels will be considered after FY 2024 appropriations are enacted, but NIH expects institutions to monitor their expenditures carefully during this period. All legislative mandates that were in effect in FY 2023 (see NOT-OD-23-072) remain in effect under this CR, as well as the salary limitation set at Executive Level II of the Federal Pay Scale (see NOT-OD-23-056) and the Ruth L. Kirschstein National Research Service Award predoctoral and postdoctoral stipend levels and tuition/fees as described in NOT-OD-23-076. The current salary cap levels remain the same until the Executive Salary Levels change—typically, January 2024.

View the Awards Funding Policy Archives.